|
iDEA: Drexel E-repository and Archives >
Drexel Academic Community >
College of Information Science and Technology >
Research Day Posters (IST) >
Finding the best evidence in biomedical literature for evidence-based medicine
Please use this identifier to cite or link to this item:
http://hdl.handle.net/1860/528
|
| Title: | Finding the best evidence in biomedical literature for evidence-based medicine |
| Authors: | Chen, Yunan |
| Keywords: | Information retrieval
Evidence based medicine
Medical informatics |
| Issue Date: | 6-Sep-2005 |
| Series/Report no.: | IST Research Day 2005 posters;no. 287C |
| Abstract: | Background: Evidence-based Medicine (EBM) is characterized by integrating individual clinical expertise with the best available external clinical evidence from systematic research. But the large amount of available biomedical literature gives healthcare practitioners much difficulty in locating the best evidence regarding each clinical question. Methods: In this study, we combined information visualization techniques with bibliographic tools to automatically extract the best external evidence out of the vast body of medical literature. We visualized the evolution of Nonsteroidal anti-inflammatory drugs (NSAID) research. Co-citation and co-keyword patterns were visualized in cluster views and time zone views of the NSAID research over 15 years (1990-2005). Our dataset combined Medline and Web of Science together. It included the MeSH terms and Publication Types (PT) such as important EBM types of meta-analysis and randomized controlled trails form Medline and cited references information from Web of Science. Results: The visualization shows 5 clusters of NASID research: 1) Alzheimer Disease, 2) Cyclooxygenase, 3) Colonic Neoplasms, 4) Adverse Effects of Selective Inhibitors, and 5) Adverse Effects of Traditional, Non-selective Inhibitors. These clusters perfectly match the previous review articles and expert opinion. The time zone graph reveals more valuable information. The keyword of “pump inhibitors” peaked twice in 1999 and again in 2004, corresponding to the emerging trend in COX-2 inhibitors research in 1999 and the withdrawal of Vioxx - one of COX-2 inhibitors by Merck & Co in 2004. The success of this case study will lead to the future design of visualization-based evidence searching tools for EBM. |
| URI: | http://hdl.handle.net/1860/528 |
| Appears in Collections: | Research Day Posters (IST)
|
Items in iDEA are protected by copyright, with all rights reserved, unless otherwise indicated.
|
www.drexel.edu
